Show
Sort by
-
- Journal Article
- A1
- open access
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic : an ESTRO-ASTRO consensus statement q
-
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01)
-
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies
-
Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer
-
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study
-
Treatment compliance and early toxicity of 3D involved-field radiotherapy (RT) and chemotherapy (CT) in a randomized study comparing induction CT followed by concurrent CT-RT with concurrent CT-RT followed by consolidation CT, in non-small-cell lung cancer (NSCLC)
-
A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer